FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2026993313> ?p ?o ?g. }

• W2026993313 endingPage "251" @default.
• W2026993313 startingPage "244" @default.
• W2026993313 abstract "In an ongoing effort to identify diagnostic ovarian cancer biomarkers, SEREX (serological analysis of recombinant cDNA expression libraries) technique was employed resulting in detection of 20 known genes, nine ESTs and one novel sequence. Interleukin-8 (IL-8) was one of ovarian cancer-associated antigens identified by SEREX screening. The objective of this study was, therefore, to evaluate the potential importance of circulating anti-IL-8 antibody as ovarian cancer biomarker.We developed and optimized a new immunofluorescent bead-based assay for detection of anti-IL-8 antibody in blood serum. Circulating IL-8 and anti-IL-8 IgG concentrations were measured in blood sera from 44 patients with early stage (I-II) ovarian cancer, 50 patients with late stage (III-IV) ovarian cancer, 37 patients with benign pelvic masses, and 80 healthy women using the bead-based assay.Our data indicate that serum contains IL-8 cytokine, anti-IL-8 antibody, and IL-8:anti-IL-8 complexes. We found that concentrations of IL-8 and anti-IL-8 antibody were elevated in sera of patients with ovarian cancer as compared with healthy controls. Logistic regression analysis of circulating concentrations of anti-IL-8 IgG in patients with stages I-II ovarian cancer versus healthy controls allowed for prediction of early ovarian cancer with 98% specificity, 65.5% sensitivity, 80.3% of patients correctly classified. Combining IL-8 and anti-IL-8 IgG with CA 125 resulted in increased classification power as compared to individual markers analyzed separately.Thus, IL-8 and anti-IL-8 autoantibody might potentially serve as additional biomarkers for ovarian cancer." @default.
• W2026993313 created "2016-06-24" @default.
• W2026993313 creator A5016153712 @default.
• W2026993313 creator A5017444641 @default.
• W2026993313 creator A5025976154 @default.
• W2026993313 creator A5032650779 @default.
• W2026993313 creator A5040250497 @default.
• W2026993313 creator A5066314287 @default.
• W2026993313 creator A5071827985 @default.
• W2026993313 creator A5076251961 @default.
• W2026993313 date "2006-08-01" @default.
• W2026993313 modified "2023-10-12" @default.
• W2026993313 title "Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancer" @default.
• W2026993313 cites W138135914 @default.
• W2026993313 cites W1528158334 @default.
• W2026993313 cites W1575529010 @default.
• W2026993313 cites W1808312293 @default.
• W2026993313 cites W1870613823 @default.
• W2026993313 cites W1967521794 @default.
• W2026993313 cites W1984363050 @default.
• W2026993313 cites W1988558959 @default.
• W2026993313 cites W1989447298 @default.
• W2026993313 cites W2010452829 @default.
• W2026993313 cites W2025591234 @default.
• W2026993313 cites W2026180995 @default.
• W2026993313 cites W2032458681 @default.
• W2026993313 cites W2044230490 @default.
• W2026993313 cites W2052892134 @default.
• W2026993313 cites W2053322239 @default.
• W2026993313 cites W2064070584 @default.
• W2026993313 cites W2066308207 @default.
• W2026993313 cites W2067488175 @default.
• W2026993313 cites W2077939324 @default.
• W2026993313 cites W2083155371 @default.
• W2026993313 cites W2101840353 @default.
• W2026993313 cites W2112590903 @default.
• W2026993313 cites W2123605040 @default.
• W2026993313 cites W2137088550 @default.
• W2026993313 cites W2144011801 @default.
• W2026993313 cites W2150285844 @default.
• W2026993313 cites W2157712078 @default.
• W2026993313 cites W2312433151 @default.
• W2026993313 cites W2328176404 @default.
• W2026993313 cites W4240172398 @default.
• W2026993313 cites W4244588312 @default.
• W2026993313 doi "https://doi.org/10.1016/j.ygyno.2005.12.011" @default.
• W2026993313 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16434085" @default.
• W2026993313 hasPublicationYear "2006" @default.
• W2026993313 type Work @default.
• W2026993313 sameAs 2026993313 @default.
• W2026993313 citedByCount "123" @default.
• W2026993313 countsByYear W20269933132012 @default.
• W2026993313 countsByYear W20269933132013 @default.
• W2026993313 countsByYear W20269933132014 @default.
• W2026993313 countsByYear W20269933132015 @default.
• W2026993313 countsByYear W20269933132016 @default.
• W2026993313 countsByYear W20269933132017 @default.
• W2026993313 countsByYear W20269933132018 @default.
• W2026993313 countsByYear W20269933132019 @default.
• W2026993313 countsByYear W20269933132020 @default.
• W2026993313 countsByYear W20269933132021 @default.
• W2026993313 countsByYear W20269933132022 @default.
• W2026993313 crossrefType "journal-article" @default.
• W2026993313 hasAuthorship W2026993313A5016153712 @default.
• W2026993313 hasAuthorship W2026993313A5017444641 @default.
• W2026993313 hasAuthorship W2026993313A5025976154 @default.
• W2026993313 hasAuthorship W2026993313A5032650779 @default.
• W2026993313 hasAuthorship W2026993313A5040250497 @default.
• W2026993313 hasAuthorship W2026993313A5066314287 @default.
• W2026993313 hasAuthorship W2026993313A5071827985 @default.
• W2026993313 hasAuthorship W2026993313A5076251961 @default.
• W2026993313 hasConcept C121608353 @default.
• W2026993313 hasConcept C126322002 @default.
• W2026993313 hasConcept C143998085 @default.
• W2026993313 hasConcept C146357865 @default.
• W2026993313 hasConcept C147483822 @default.
• W2026993313 hasConcept C151730666 @default.
• W2026993313 hasConcept C159654299 @default.
• W2026993313 hasConcept C163764329 @default.
• W2026993313 hasConcept C203014093 @default.
• W2026993313 hasConcept C2778690821 @default.
• W2026993313 hasConcept C2780427987 @default.
• W2026993313 hasConcept C2781197716 @default.
• W2026993313 hasConcept C45189115 @default.
• W2026993313 hasConcept C55493867 @default.
• W2026993313 hasConcept C71924100 @default.
• W2026993313 hasConcept C86803240 @default.
• W2026993313 hasConcept C90924648 @default.
• W2026993313 hasConceptScore W2026993313C121608353 @default.
• W2026993313 hasConceptScore W2026993313C126322002 @default.
• W2026993313 hasConceptScore W2026993313C143998085 @default.
• W2026993313 hasConceptScore W2026993313C146357865 @default.
• W2026993313 hasConceptScore W2026993313C147483822 @default.
• W2026993313 hasConceptScore W2026993313C151730666 @default.
• W2026993313 hasConceptScore W2026993313C159654299 @default.
• W2026993313 hasConceptScore W2026993313C163764329 @default.
• W2026993313 hasConceptScore W2026993313C203014093 @default.
• W2026993313 hasConceptScore W2026993313C2778690821 @default.

• next